Radic8 ViruskillerTM technology was funded in 2004 by the Korean Government in response to SARS. The VirusKiller™ technology, which combines air purification and photocatalytic oxidation, is now in over 80% of all hospitals and schools in South Korea with over 370,000 installations.
Radic8 technology uses a two-stage process: filtration followed by photocatalytic oxidation technology. The Viruskiller™ Technology has a 99.9999% kill rate–in a single pass–against viruses similar to SARS-CoV-2 or harder-to-kill, such as Coronavirus DF2, Adenovirus, Influenza virus, and Poliovirus.
Viruskiller™ technology has 14 patents granted in South Korea and won Top Innovation Company Award in 2018 for Infection Control as determined by InfectionControl.tips.
Hextio by Radic8:
- Designed for reception desks and small offices
- Covers spaces up to 215 square feet*
- 99.9999% kill rate in a single air exchange
- Tested against Coronavirus DF2, Adenovirus, Influenza virus, and Poliovirus
- Technology combines a pre-filter, HEPA filter, and activated carbon
- Compact, powerful and portable
- Low running costs
*Assuming 8' ceiling
This product is not FDA cleared or approved. Marketed under FDA’s Enforcement Policy for Air Purifiers, during the COVID-19 public health emergency. Tested on viruses that are representative of SARS-CoV-2, but not SARS-CoV-2 itself. This product has not been tested on SARS-CoV-2. This product is for medical purposes and should be used as an adjunct to personal protective equipment (PPE) and other infection control procedures. When using Viruskiller™, basic safety precautions should be observed, and instructions should be read to reduce the risk of fire, electric shock, or injury; the appliance should not be used by children or adults with reduced capabilities. Looking directly at an ultra-violet light may cause permanent damage to the eyes. Please visit https://henryscheindigital.com/radic8